WilliamWBusseMD

Allergy & Immunology • Madison, WI

Asthma & Allergic Conditions

Professor of Allergy & Immunology, University Wisc

Join to view full profile

Are you Dr. Busse?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
5510 South Hill Dr
Madison, WI 53705
Phone+1 608-263-6180

Fax+1 608-263-9103

Summary

Dr. William Busse, MD is an allergist/immunologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Minnesota. He is a Professor of Allergy & Immunology at University Wisc.

Education & Training

University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1970 - 1973
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1967 - 1968
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1966 - 1967
University of Wisconsin School of Medicine & Public HealthClass of 1966
University of Wisconsin Hospitals and ClinicsResidency, Allergy and Immunology

Certifications & Licensure

WI State Medical License 1967 - 2021
MN State Medical License 1973 - 1984
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents Start of enrollment: 2004 Aug 01
Completed
Not Applicable
Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults Start of enrollment: 2004 Apr 01
Terminated
The Effect of Salmeterol on Eosinophil (EOS) Function Start of enrollment: 2003 Nov 01
Completed
Not Applicable
ICATA Asthma Mechanistic Study Start of enrollment: 2006 Oct 01
Completed
Inner-City Anti-IgE Therapy for Asthma Start of enrollment: 2006 Oct 01
Completed
Phase 4
Inhaled Steroid Treatment as Regular Therapy in Early Asthma Start of enrollment: 1996 Oct 01
Completed
Phase 4
Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma Start of enrollment: 2009 Oct 01
Completed
Phase 2
Asthma Phenotypes in the Inner City Start of enrollment: 2011 Aug 01
Completed
Best African American Response to Asthma Drugs Start of enrollment: 2014 Feb 01
Completed
Phase 3
Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations Start of enrollment: 2014 Jul 01
Completed
Phase 3
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation Start of enrollment: 2014 Sep 01
Completed
Not Applicable
A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA Start of enrollment: 2014 Nov 19
Completed
Phase 3
A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children Start of enrollment: 2017 Nov 07
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

851 citations
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomi...
J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta
Lancet. 2016-10-29
170 citations
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
Bora study investigators
The Lancet. Respiratory Medicine. 2019-01-01
57 citations
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
Paul M. O'Byrne, Eugene R. Bleecker, Eric D. Bateman, William W. Busse, Ashley Woodcock
The European Respiratory Journal. 2014-03-01

Press Mentions

Antibody Treatment Reduces Asthma Attacks in Children Living in Disadvantaged Urban AreasAugust 17th, 2022
School Pest Management Program Significantly Reduced Asthma Symptoms in KidsSeptember 10th, 2021
FASENRA (Benralizumab) Shows Consistent Safety and Sustained Efficacy in Long-Term Phase III BORA Trial in Severe Eosinophilic AsthmaNovember 23rd, 2019
Join now to see all

Grant Support

Severe Asthma From Respiratory InfectionsNational Heart, Lung, And Blood Institute2001–2010
Characterization Of Subjects With Severe AsthmaNational Center For Research Resources2004–2007
Functional Activity Of Airway Eosinophils In Allergic DiseaseNational Center For Research Resources2000–2007
Cytokine/Chemokine Response In Asthma Exacerbations Due To ColdsNational Center For Research Resources2004–2006
Scor--Cellular And Molecular Mechanisms Of AsthmaNational Heart, Lung, And Blood Institute1997–2006
Role And Contribution Of Eosinophils To The Pathogenesis Of AsthmaNational Center For Research Resources2004–2005
Eosinophil Priming And Activation In AsthmaNational Heart, Lung, And Blood Institute2002–2005
Airway Inflammation And Remodeling In AsthmaNational Center For Research Resources2000–2005
Role Of The Neutrophil In Subjects With Severe AsthmaNational Center For Research Resources2004
Role Of Cytokine Dysregulation In An In Vivo Model Of Rhinovirus 16National Center For Research Resources2004
Phase II Evaluation Of Allergen Immunotherapy Co-Administered With OmalizumabNational Center For Research Resources2004
Aadrc -- Mechanisms Of Virus-Induced AsthmaNational Institute Of Allergy And Infectious Diseases2001–2004
Wisconsin Allergy And Immunology Research Training ProgNational Institute Of Allergy And Infectious Diseases2000–2003
Cytokine Dysregulation In RV Provoked AsthmaNational Institute Of Allergy And Infectious Diseases2001–2002
Mechanisms Of Rhinovirus Induced AsthmaNational Heart, Lung, And Blood Institute1998–2002
Regulation Of Eosinophilic Inflammation In AsthmaNational Heart, Lung, And Blood Institute1997–2001
Trial Of Nebulized Rhu Interleukin-12 In Patients With Mild AsthmaNational Center For Research Resources2000
Inhaled L-808065 On Antigen Challenge Response In Mild AsthmaNational Center For Research Resources2000
Virus Regulation Of Cyto/Chemokine Generation In Epithelial Cells &MacrophagesNational Institute Of Allergy And Infectious Diseases1997–2000
Aaidcrc - Mechanisms Of Virus-Induced AsthmaNational Institute Of Allergy And Infectious Diseases1997–2000
Rv-16 On Airway Inflammation And Expression Of Lower Airway InfectionNational Center For Research Resources1997
Airway Biology Of Nocturnal AsthmaNational Heart, Lung, And Blood Institute1996–1997
Airway Biology Of Rhinovirus 16 Infection And AsthmaNational Institute Of Allergy And Infectious Diseases1988–1997
Function Of The Isolated Eosinophil In AsthmaNational Institute Of Allergy And Infectious Diseases1986–1997
Airway Biology Of Rhinovirus 16 Infection In AsthmaNational Center For Research Resources1995–1996
Aaidcrc Mechanisms Of Virus Induced AsthmaNational Institute Of Allergy And Infectious Diseases1993–1996
Mechanisms Of Virus-Induced AsthmaNational Heart, Lung, And Blood Institute1989–1996
Effect Of Uniphyl On Immediate And LATE Asthmatic Reactions From Inhaled AntigenNational Center For Research Resources1995
Asthma And Allergic Disease Center GrantNational Institute Of Allergy And Infectious Diseases1992
Mechanisms Of Virus Induced AsthmaNational Institute Of Allergy And Infectious Diseases1985–1988

Professional Memberships

American Academy of Allergy Asthma and Immunology - AAAAI
Fellow